Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Glutathione is an important nutrient for brain function and loss of glutathione has been
implicated in Parkinson's disease. Glutathione is an antioxidant made in the body out of
three amino acids, the nutrients that make up protein. This study will determine whether
administration of either dose of glutathione, as a nasal spray, improves PD symptoms over
time in a population of individuals with Parkinson's disease (PD).
Phase:
Phase 2
Details
Lead Sponsor:
Bastyr University
Collaborator:
Michael J. Fox Foundation for Parkinson's Research